Wolfe Research Weighs on West Pharmaceutical Services Inc (WST) Stock

On May 31, Wolfe Research initiated sum of West Pharmaceutical Services Inc (NYSE:WST) banal with an Outperform standing and a terms people of $375. The brokerage based its determination connected the company’s concern fundamentals and valuation history.

Based connected Wolfe Research’s net estimates for West Pharmaceutical Services, the terms people represents 40 times projected EPS for 2027. According to the firm, WST banal has typically traded astir 40 times net implicit the past 15 years.

Additionally, the steadfast noted that West Pharmaceutical has historically commanded a premium of much than 100% to the S&P 500. Furthermore, the steadfast pointed retired that adjacent erstwhile compared with companies successful its ain sector, West Pharmaceutical’s banal has historically traded astatine a important premium of 75%.

Therefore, Wolfe Research sees its valuation for West Pharmaceutical banal arsenic supported by some humanities trading patterns and the outlook for aboriginal net growth.

West Pharmaceutical Services Inc (NYSE:WST) manufactures packaging and transportation systems for injectable medicines. Its portfolio includes rubber stoppers, seals, plungers, prefilled syringes, and self-injection devices. Pharmaceutical and biotechnology companies usage these components to safely store and administer drugs.

While we admit the imaginable of WST arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Investors’ Stock Portfolio: Top 10 Penny Stocks To Buy and 10 Most Shorted Mid-Cap and Small-Cap Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey connected Google News.